Home | Welcome to Contract Pharma   
Last Updated Friday, November 28 2014
Print RSS Feed

Breaking News

Related Searches:
May 26, 2010
Covidien has entered a definitive agreement to sell its Specialty Chemicals business to an affiliate of New Mountain Capital, for $280 million in cash.  Read More »
May 26, 2010
A.P. Pharma, Inc. has hired a consulting practice in regulatory affairs to lead the FDA Review Process for its lead product candidate, APF530 for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting.  Read More »
May 26, 2010
Genzyme received marketing approval from the FDA for Lumizyme (alglucosidase alfa), produced at the 4000 L bioreactor scale at its manufacturing facility in Geel, Belgium.  Read More »
May 26, 2010
R&D shakeup at AZ and Pfizer  Read More »
May 25, 2010
inVentiv Clinical has expanded its global alliance with the additions of Protech Pharmaservices Corp. (PPC), Ecron Acunova and RDDA.   Read More »
May 25, 2010
The FDA has finalized the terms of the consent decree regarding Genzyme’s Allston manufacturing plant, subject to approval by the U.S. District Court for the District of Massachusetts.   Read More »
May 25, 2010
Penn Pharma has successfully completed a recent FDA GMP inspection of its facility in South Wales, UK.   Read More »
May 25, 2010
Dr. Edward Huber has been named director of Analytical Development and Quality Control, Girindus.   Read More »
May 24, 2010
Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs.   Read More »
May 24, 2010
ICON has acquired Timaq Medical Imaging, a provider of imaging services to pharma/biopharma firms, based in Zurich, Switzerland.  Read More »
May 24, 2010
Biogen Idec and Abbott began enrollment in a global Phase III study evaluating the efficacy and safety of daclizumab compared to interferon beta-1a (AVONEX) in patients with relapsing-remitting multiple sclerosis (RRMS).  Read More »
May 24, 2010
260 employees to be laid off as CPL consolidates operations.  Read More »
May 21, 2010
Abbott has entered a definitive agreement with Piramal Healthcare Ltd. to acquire Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for $2.1 billion, plus $400 million annually for the next fo  Read More »
May 21, 2010
Ablynx and Pfizer have extended their research collaboration and license agreement to discover and develop Nanobody-based therapeutics against tumor necrosis factor alpha (TNF-alpha), for another year.  Read More »
May 21, 2010
Ligand Pharmaceuticals has purchased certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by MedImmune, an AstraZeneca subsidiary.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On